June 9, 2025 Health Biotech & Pharma CLE Institute

8:30 a.m. - 9:00 a.m.
Registration

9:00 a.m. - 10:00 a.m.
"Hot Topics in Cybersecurity and Privacy: Safeguarding Innovation in Healthcare, Biotech & Pharma"
Presented by Hogan Lovells

As the healthcare, biotech, and pharmaceutical sectors grow increasingly data-driven, the stakes for cybersecurity and privacy have never been higher. This panel will explore the latest regulatory developments, emerging cyber threats, and best practices for protecting sensitive patient data, proprietary research, and digital infrastructure. Hear from industry leaders and legal advisers as they unpack real-world breaches, evolving global standards, and strategies for building resilient, compliant data ecosystems in an era of rapid innovation.

Speakers:

• Jasmeet K. Ahuja, Partner, Hogan Lovells
• Nathan Salminen, Partner, Hogan Lovells
• Alex Erin, Associate, Hogan Lovells
• Jason Herpel, VP, Associate General Counsel, EyePoint Pharmaceuticals

10:15 a.m. - 11:15 a.m.
"Trends and Developments in Preemption in Life Sciences Litigation"
Presented by Shook, Hardy & Bacon, LLP

The presentation will focus on recent decisions around preemption that is a critical defense for companies in litigation in the life sciences space.  As part of that, we will explore how the recent decision in the Loper case factors into the preemption context.

Speakers:

• Thomas Sullivan, Partner, Shook Hardy & Bacon LLP
• Kevin Dulaney, Associate, Shook Hardy & Bacon LLP
• David Rifkind, Chief Legal Officer, Caidya

11:30 a.m. - 12:30 p.m.
"Licensing as an Alternative to M&A"
Presented by Troutman Pepper Locke

In the current landscape, life sciences companies are facing a volatile public market, fierce competition for public financing and FDA staffing shortages that threaten to slow down approval pathways. Join Troutman Pepper Locke attorneys, Deborah Spranger and EA Weeks, and CSL General Counsel Amy Demediuk as they explore how licensing and collaborations offer a strategic alternative to M&A by allowing companies to overcome funding challenges, share expertise and resources, and accelerate the path to market. 

Speaker:

• Deborah L. Spranger, Partner, Troutman Pepper Locke
• EA Weeks, Ph.D., Counsel, Troutman Pepper Locke 
• Amy Demediuk, General Counsel, Global R&D and Strategy, CSL Behring